Research & Presentations

Aneesh Garg, DO, CAQ · Double Board-Certified · The Regen Doc

Aneesh Garg, DO, CAQ, known as The Regen Doc, does not only treat patients. He generates the evidence and teaches the field. In 2026 he presents original research tied to the American Shockwave Training Institute (ASTI), which he founded and directs, at the American Society for Medical Shockwave Treatment (ASMST) and the International Society for Medical Shockwave Treatment (ISMST) in Madrid, Spain. He presented on shockwave, PRP, and stem cell therapy in a CuraMedix-sponsored breakout at IOF MAX in Aurora, Colorado, lectured at the Regenerative Medicine Training Institute (RMTI) in 2025, and leads the hands-on ASTI courses he runs each year. The physician who researches and teaches the method is the one who delivers it at Dynamic Athlete.

When you choose a clinic for shockwave, PRP, or stem cell therapy, it matters whether your physician only attends the conferences or stands at the podium. This page documents the 2026 venues, the topics, and why presenting research is a verifiable signal, not a marketing line.

The Decision

A physician who presents at the professional societies is being judged by the same peers who set the field’s standards. Posters and podium talks are submitted, reviewed, and shown to the people who define how shockwave and orthobiologics are practiced. That is a different proposition than a clinic whose training is a one-day vendor introduction.

For a Boulder patient, the takeaway is simple. The clinician who researches the method and brings the data to ASMST and ISMST is the same clinician who treats you at Dynamic Athlete.

Key Takeaways
  • Presentations across 2023 to 2026, two audiences. Dr. Garg presents at the shockwave societies ASMST and ISMST (Madrid, Spain), and on the orthobiologics side at IOF MAX (Aurora, Colorado), the CuraMedix industry sessions at ITRR (Phoenix and Boston), and the Regenerative Medicine Training Institute (RMTI, Jupiter, Florida).
  • He generates the evidence, not only cites it. The ASMST and ISMST posters are tied to original research from the American Shockwave Training Institute (ASTI), which he founded and directs.
  • He teaches the field. As a CuraMedix Key Opinion Leader and teaching faculty at RMTI and Rocky Vista University, he trains the clinicians who deliver focused shockwave. Presenting research is a verifiable experience signal, not an efficacy claim.
  • Over 90% of our patients self-report a 75% or greater improvement, all without surgery, with the Dynamic protocols at Dynamic Athlete.

Presentations, by year

Research and clinical lectures across two audiences: the shockwave societies, and the orthobiologics field. Each row is a factual record of the year, venue, and topic, not a claim of outcomes.

What these are:
ASMST, the American Society for Medical Shockwave Treatment (the U.S. shockwave society) ·
ISMST, the International Society for Medical Shockwave Treatment (the global shockwave society) ·
IOF MAX, the Interventional Orthobiologics Foundation MAX meeting ·
ASTI, the American Shockwave Training Institute, founded and directed by Dr. Garg ·
RMTI, the Regenerative Medicine Training Institute ·
ITRR, the Institute for Tissue Regeneration & Repair Conference (held in Phoenix and Boston) ·
CuraMedix and Cervos, regenerative-medicine technology companies.

Two shockwave authorities, one orthobiologics venue

ASMST and ISMST are where shockwave research is judged by the field. IOF MAX is the orthobiologics gathering, so it is a PRP and stem cell authority signal, and a Colorado one, close to the patients Dr. Garg treats.

2026

  • ASMST, Boston, MA — Research poster
    “Same Device. Different Delivery.” Shockwave utilization and implementation after structured ASTI training
  • ISMST, Madrid, Spain — Research poster
    “Same Device. Different Delivery.” The same poster, presented at the global shockwave society
  • ASTI, Boulder, CO — Hands-on course, lead instructor
    Clinical Shockwave Implementation Training: January, July, and November sessions
  • IOF MAX, Aurora, CO — Industry breakout, CuraMedix-sponsored
    Shockwave, PRP, and stem cell therapy
  • ITRR, Phoenix, AZ — Podium talk, CuraMedix
    Shockwave with PRP and stem cells
  • ITRR, Boston, MA — Podium talk, CuraMedix
    Shockwave with PRP and stem cells

2025

  • ASTI, Boulder, CO — Hands-on course, lead instructor
    Clinical Shockwave Implementation Training: July and November sessions
  • RMTI, Jupiter, FL — Clinical lecture
    Combining focused shockwave with PRP and stem cells
  • ITRR, Phoenix, AZ — Podium talk, CuraMedix
    Shockwave with PRP and stem cells
  • ITRR, Boston, MA — Podium talk, CuraMedix
    Shockwave with PRP and stem cells

2024

  • ITRR, Phoenix, AZ — Podium talk, CuraMedix
    Shockwave with PRP and stem cells
  • ITRR, Boston, MA — Podium talk, CuraMedix
    Shockwave with PRP and stem cells

2023

  • ITRR, Boston, MA — Podium talk, Cervos
    PRP and stem cell therapy

What each lane of authority means

These split into two audiences. Here is what each builds.

The shockwave societies: ASMST and ISMST

Dr. Garg presented the same ASTI poster, “Same Device. Different Delivery.”, at both ASMST (U.S.) and ISMST (Spain). It studies how a clinician’s delivery and use of shockwave change after structured ASTI training rather than a one-day vendor introduction. It is implementation research: it examines the operator, not the machine. These are the two venues, U.S. and global, where the field itself reviews shockwave research.

The orthobiologics field: IOF MAX, CuraMedix, and RMTI

At IOF MAX in Aurora, Colorado, an orthobiologics venue (the field of PRP, bone marrow aspirate, and adipose-derived therapies), Dr. Garg presented on shockwave, PRP, and stem cell therapy in a CuraMedix-sponsored industry breakout. He also teaches that combination directly: at the Regenerative Medicine Training Institute (RMTI) in 2025, and as lead instructor of the American Shockwave Training Institute (ASTI) hands-on courses he runs each year. As a CuraMedix Key Opinion Leader, he advises on the Storz technology, not only uses it.

Why this lifts every service, not only shockwave

The thread across all four venues is one physician. The Regen Doc researches the method, teaches it to other clinicians, and delivers it himself at Dynamic Athlete. A patient evaluating PRP, stem cell, or shockwave care is choosing the clinician whose work is reviewed by the professional societies and taught at ASTI, RMTI, and Rocky Vista University. The authority and the care are the same person.

ISMST poster: “Same Device. Different Delivery.” — what it found

A survey of clinicians trained at ASTI (n=16, self-reported, 1 to 3 months after training) found that structured training measurably shifts how a clinician delivers shockwave. Across five domains, clinical confidence, practice adoption, technique and protocol, perceived patient-outcome impact, and adoption metrics, 68.75 to 100 percent of respondents reported a strong or exceptional impact. Every respondent reported using shockwave with more patients and integrating it into more treatment plans after training.

The honest framing is the point: this is implementation research. It measures clinician behavior and perception, in a small self-reported cohort, not patient clinical outcomes. The same device, in trained versus untrained hands, gets delivered differently. That is exactly why who performs your shockwave, and how they were trained, matters.

True shockwave, by the classification

ISMST, ASMST, and ASTI all treat focused ESWT and radial pressure wave as distinct technologies. Focused ESWT is the real, evidence-backed treatment, with a defined focal point. Radial is a separate, more superficial modality. When Dr. Garg’s posters reference shockwave, they mean focused ESWT.

What Dynamic Shockwave+ delivers

Dynamic Shockwave+ delivers true focused ESWT and EMTT every session, with radial only as an adjunct when indicated, on the Storz gold-standard system: the same equipment Dr. Garg teaches other clinicians to use at ASTI. Read the full focused vs radial public service notice.

Related Reading

Over 90% of our patients self-report a 75% or greater improvement following treatment.

Across PRP, Stem Cell, Shockwave, EXOMIND, and EMSELLA. Tracked across active adults, postpartum patients, athletes, and surgery-avoiders.

Pages